ASSEMBLY AND EXTRACELLULAR RELEASE OF CHIMERIC HIV-1 PR55(GAG) RETROVIRUS-LIKE PARTICLES

被引:55
作者
WAGNER, R
DEML, L
FLIESSBACH, H
WANNER, G
WOLF, H
机构
[1] INST MED MIKROBIOL,W-8400 REGENSBURG,GERMANY
[2] LMU MUNCHEN,INST BOT,MUNICH,GERMANY
关键词
D O I
10.1006/viro.1994.1175
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The HIV-1 Pr55(gag) precursors were previously shown to assemble and bud from a variety of different cell types as noninfectious virus-like particles (VLPs) resembling immature HIV virions. The use of these VLPs as an immunogenic and autologous carrier component may allow the presentation of defined epitopes deduced from reading frames other than gag to the immune system, thereby avoiding the induction of adverse immune responses. In order to identify domains within Pr55(gag) that can be replaced by immunologically relevant epitopes without affecting its capacity to assemble into VLPs, we deleted three domains of a predicted high surface probability. Deletion of amino acids 211-241 within p24CA and amino acids 436-471 within the p6LI portion of Pr55(gag) had no effect on the assembly, ultrastructure, biophysical properties, and yields of mutant VLPs when expressed via recombinant vaccinia viruses in mammalian cells. Deletion of amino acids 99-154 overlapping the p17MA/p24CA cleavage site completely abolished the capacity of the gag polyprotein to form VLPs and led to a reduction of immature Pr55 VLPs released into the cell-culture supernatants when coexpressed with wild-type Pr55(gag). In contrast, assembly and budding of chimeric VLPs could be demonstrated after replacing amino acids 211-241 and 436-471 by immunologically relevant epitopes derived from reading frames other than pr55(gag) (e.g., vs loop; CD4-binding-domain; nef-CTL epitope) or after fusion of these sequences to the carboxy terminus of Pr55(gag). The importance of these data for the development of novel HIV candidate vaccines is discussed. (C) 1994 Academic Press, Inc.
引用
收藏
页码:162 / 175
页数:14
相关论文
共 59 条
  • [21] ANALYSIS OF PROTEIN EXPRESSION AND VIRUS-LIKE PARTICLE FORMATION IN MAMMALIAN-CELL LINES STABLY EXPRESSING HIV-1 GAG AND ENV GENE-PRODUCTS WITH OR WITHOUT ACTIVE HIV PROTEINASE
    KRAUSSLICH, HG
    OCHSENBAUER, C
    TRAENCKNER, AM
    MERGENER, K
    FACKE, M
    GELDERBLOM, HR
    BOSCH, V
    [J]. VIROLOGY, 1993, 192 (02) : 605 - 617
  • [22] DELINEATION OF A REGION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 GLYCOPROTEIN CRITICAL FOR INTERACTION WITH THE CD4 RECEPTOR
    LASKY, LA
    NAKAMURA, G
    SMITH, DH
    FENNIE, C
    SHIMASAKI, C
    PATZER, E
    BERMAN, P
    GREGORY, T
    CAPON, DJ
    [J]. CELL, 1987, 50 (06) : 975 - 985
  • [23] GENERAL-METHOD FOR PRODUCTION AND SELECTION OF INFECTIOUS VACCINIA VIRUS RECOMBINANTS EXPRESSING FOREIGN GENES
    MACKETT, M
    SMITH, GL
    MOSS, B
    [J]. JOURNAL OF VIROLOGY, 1984, 49 (03) : 857 - 864
  • [24] THE T4 GENE ENCODES THE AIDS VIRUS RECEPTOR AND IS EXPRESSED IN THE IMMUNE-SYSTEM AND THE BRAIN
    MADDON, PJ
    DALGLEISH, AG
    MCDOUGAL, JS
    CLAPHAM, PR
    WEISS, RA
    AXEL, R
    [J]. CELL, 1986, 47 (03) : 333 - 348
  • [25] ANALYSIS OF HIV PARTICLE FORMATION USING TRANSIENT EXPRESSION OF SUBVIRAL CONSTRUCTS IN MAMMALIAN-CELLS
    MERGENER, K
    FACKE, M
    WELKER, R
    BRINKMANN, V
    GELDERBLOM, HR
    KRAUSSLICH, HG
    [J]. VIROLOGY, 1992, 186 (01) : 25 - 39
  • [26] LYMPHOCYTE-T AND LYMPHOCYTE-B RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 IN MACAQUES IMMUNIZED WITH HYBRID HIV HEPATITIS-B SURFACE-ANTIGEN PARTICLES
    MICHEL, ML
    MANCINI, M
    RIVIERE, Y
    DORMONT, D
    TIOLLAIS, P
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (05) : 2452 - 2455
  • [27] COMPUTER-ASSISTED ANALYSIS OF ENVELOPE PROTEIN SEQUENCES OF 7 HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES - PREDICTION OF ANTIGENIC EPITOPES IN CONSERVED AND VARIABLE REGIONS
    MODROW, S
    HAHN, BH
    SHAW, GM
    GALLO, RC
    WONGSTAAL, F
    WOLF, H
    [J]. JOURNAL OF VIROLOGY, 1987, 61 (02) : 570 - 578
  • [28] NEIDRIG M, 1992, VACCINES 93
  • [29] HIV-1 GAG-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T DEFINED WITH RECOMBINANT VACCINIA VIRUS AND SYNTHETIC PEPTIDES
    NIXON, DF
    TOWNSEND, ARM
    ELVIN, JG
    RIZZA, CR
    GALLWEY, J
    MCMICHAEL, AJ
    [J]. NATURE, 1988, 336 (6198) : 484 - 487
  • [30] HUMAN IMMUNODEFICIENCY VIRUS TYPE 1-NEUTRALIZING MONOCLONAL-ANTIBODIES WHICH REACT WITH P17 CORE PROTEIN - CHARACTERIZATION AND EPITOPE MAPPING
    PAPSIDERO, LD
    SHEU, M
    RUSCETTI, FW
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (01) : 267 - 272